A multicenter, randomized, double-blind clinical study to examine the efficacy and safety of Zarzenda� in comparison to Elidel� in the management of mild to moderate atopic dermatitis in children and adolescents.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest